RxSight, Inc. Quarterly Return On Equity in % from Q4 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
RxSight, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2020 to Q3 2024.
  • RxSight, Inc. Return On Equity for the quarter ending September 30, 2024 was -14 %, a 64.8% increase year-over-year.
  • RxSight, Inc. annual Return On Equity for 2023 was -31.2 %, a 51.1% increase from 2022.
  • RxSight, Inc. annual Return On Equity for 2022 was -63.7 %, a 207% decline from 2021.
  • RxSight, Inc. annual Return On Equity for 2021 was 59.7 %.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -14 +25.8 +64.8% Jul 1, 2024 Sep 30, 2024
Q2 2024 -19.3 +29.4 +60.3% Apr 1, 2024 Jun 30, 2024
Q1 2024 -27.7 +28.9 +51.1% Jan 1, 2024 Mar 31, 2024
Q4 2023 -31.2 +32.6 +51.1% Oct 1, 2023 Dec 31, 2023
Q3 2023 -39.8 +17.5 +30.5% Jul 1, 2023 Sep 30, 2023
Q2 2023 -48.7 -0.67 -1.39% Apr 1, 2023 Jun 30, 2023
Q1 2023 -56.6 +184 +76.5% Jan 1, 2023 Mar 31, 2023
Q4 2022 -63.7 -123 -207% Oct 1, 2022 Dec 31, 2022
Q3 2022 -57.2 -60.2 -2023% Jul 1, 2022 Sep 30, 2022
Q2 2022 -48.1 -38.2 -389% Apr 1, 2022 Jun 30, 2022
Q1 2022 -241 -231 -2551% Jan 1, 2022 Mar 31, 2022
Q4 2021 59.7 +65.9 Oct 1, 2021 Dec 31, 2021
Q3 2021 2.98 Jul 1, 2021 Sep 30, 2021
Q2 2021 -9.83 Apr 1, 2021 Jun 30, 2021
Q1 2021 -9.08 Jan 1, 2021 Mar 31, 2021
Q4 2020 -6.18 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.